SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-023947
Filing Date
2024-06-14
Accepted
2024-06-14 17:30:20
Documents
14
Period of Report
2024-06-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 64172
2 ex10-1.htm EX-10.1 183617
  Complete submission text file 0001493152-24-023947.txt   459986

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE immx-20240611.xsd EX-101.SCH 3015
4 XBRL LABEL FILE immx-20240611_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE immx-20240611_pre.xml EX-101.PRE 22359
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3814
Mailing Address 10573 W. PICO BLVD. #58 LOS ANGELES CA 90064
Business Address 11400 WEST OLYMPIC BLVD. SUITE 200 LOS ANGELES CA 90064 (888) 958-1084
Immix Biopharma, Inc. (Filer) CIK: 0001873835 (see all company filings)

IRS No.: 454869378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41159 | Film No.: 241046130
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)